Medicaid|Medicare|CHIP Services Dental Association (MSDA), a national nonprofit membership organization dedicated to advocating for the delivery of quality-based oral health care services for Medicaid, Medicare and CHIP beneficiaries, has launched a national campaign aimed at reducing opioid use for postsurgical dental pain management. The campaign will target state Medicaid agencies, health plans, professional educational institutions, and providers to inform them of the risks associated with opioid overprescribing, as well as the availability of effective opioid alternatives.
MSDA will seek partnerships with stakeholders across various sectors to identify solutions to the overuse and abuse of opioids. Pacira BioSciences is the first partner to join this national initiative. Together, they will build and implement a national strategy to increase awareness, educate, and change the trajectory of postsurgical dental pain management away from the use of opioids to a multimodal, opioid-free approach.
The post National Campaign Launched to Reduce Dental Related Opioid Misuse and Abuse appeared first on Decisions in Dentistry.